Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
GProv›
Analysis
AddedJun 25, 2026
UpdatedJun 25, 2026
GProv

GProv

GProv is the AI health navigator for expats and travellers in 20+ countries.

HQ
San Francisco, CA, US
Founded
2021
Loading
Overview
Analysis
Compare
Fundraising
Employees
News
Website

Contents

  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths
  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths

Product Overview

GProv is the definitive AI health navigator and complete medical records platform for expats, frequent travellers and global citizens living across 20+ countries.

Combining Appi AI (voice, text, image analysis in 40+ languages), a vetted Find Care directory, patient-owned encrypted PAMI vault, Travel for Health concierge and full provider EHR-lite with HL7/FHIR interoperability, GProv delivers borderless, privacy-first care without tracking or ads. Free core access, Pro upgrades available. Built by Kollitech in San Francisco, founded 2021.

GProv delivers an AI health navigator for expats and frequent travellers across 20+ countries. The platform combines Appi AI for symptom guidance, triage, image analysis, voice commands, multi-language support, drug scanning, and a vetted global provider network with a patient-owned clinical vault and travel concierge.

It also equips providers with an EHR-lite supporting e-prescriptions, SOAP notes, HL7/FHIR/Mirth interoperability and full HIPAA compliance, giving patients control while enabling seamless cross-border care without borders or tracking friction.

GProv AI Health Navigator, powered by Appi AI, delivers instant symptom assessment, triage recommendations, and drug interaction scanning. It maintains a patient-controlled clinical vault with full history, labs, and documents under AES-256 encryption.

Users access a global Find Care directory across 20+ countries, Travel for Health concierge, second opinions, and ER finder. The iOS app supports voice and 40+ languages.

For providers, GProv supplies EHR-lite tools: e-prescribing, SOAP notes, orders, care plans, and HL7 v2/FHIR R4 interoperability through Mirth Connect. It supports billing for virtual care and remote monitoring.

Market Outlook

Cross-border healthcare demand is rising with frequent travel, expat populations and fragmented records across countries. AI navigation that combines patient control, vetted providers and interoperable clinical tools can cut costs and delays dramatically for individuals and health systems.

GProv is positioned for rapid adoption among travellers, digital nomads, insurers and providers in 20+ countries seeking a unified, privacy-first layer that turns scattered data into actionable, portable care.

Rising cross-border travel and expat populations drive demand for portable, interoperable health records. Digital health adoption accelerates with AI triage tools that reduce unnecessary ER visits and improve care coordination globally.

Medical tourism and remote patient monitoring markets expand rapidly. Platforms that support HL7/FHIR and multi-country provider networks gain advantage as regulations emphasize patient data access and privacy.

GProv is positioned to capture growth among frequent travelers and digital-first patients seeking unified records without borders. Subscription and per-encounter models align with value-based and direct-pay care trends.

Competitive Advantages

GProv stands out with true patient ownership of records, HIPAA-grade encryption, 40+ language AI, and vetted providers in 20+ countries plus full interoperability for providers. Unlike fragmented telehealth or directory apps it combines navigation, clinical vault and provider EHR-lite in one controlled platform.

Free patient tier with paid clinical billing removes adoption friction while delivering auditable, portable care across borders without data leakage or vendor lock-in.

GProv unifies a patient-owned health identity that travels across borders. It combines AI guidance with clinical tools and interoperability in one HIPAA platform.

A vetted provider network spans 20+ countries. Medical travel concierge and history-aware drug scanners add unique value. Forty-plus language support with voice sets it apart.

Free access for patients and provider billing integrations like Medicare CCM distinguish the platform. Client-side encryption and no ad tracking further differentiate GProv from competitors.